EuCorVac-19 EuCorVac-19, a COVID-19 vaccine candidate developed by EuBiologics and POP Biotechnologies BUFFALO, N.Y., ...

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...

HOUSTON, TX / ACCESSWIRE / September 27, 2024 / MasterWord is honored to announce its partnership with UNESCO, within its ...

Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.The £3 ...

PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million ...

SmartHMS, a leading healthcare management solutions provider based in India, is proud to announce the ongoing success and ...

The global diabetic gastroparesis treatment market is poised for significant growth, driven by the increasing prevalence of ...

Study resultsDREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update 27.09.2024 / 22:30 CET/CESTThe issuer is solely responsible for the content of this ...

SAN DIEGO, CA / ACCESSWIRE / September 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe ...

Humaneva CEO - Tomasz D?browski WARSAW, Poland, September 27, 2024 (Newswire.com) - Humaneva Inc. has entered into a ...

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance ...

Epitopea, a transatlantic cancer immunotherapy company, and CQDM are proud to announce the launch of a collaborative research project between Epitopea and Université de Montréal (UdeM), a leading ...